Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

The objective of the study was to use CD146 mRNA to predict the evolution of patients with non-metastatic clear cell renal cell carcinoma (M0 ccRCC) towards metastatic disease, and to use soluble CD146 (sCD146) to anticipate relapses on reference treatments by sunitinib or bevacizumab in patients wi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Theranostics
Glavni autori: Dufies, Maeva, Nollet, Marie, Ambrosetti, Damien, Traboulsi, Wael, Viotti, Julien, Borchiellini, Delphine, Grépin, Renaud, Parola, Julien, Giuliano, Sandy, Helley-Russick, Dominique, Bensalah, Karim, Ravaud, Alain, Bernhard, Jean-Christophe, Schiappa, Renaud, Bardin, Nathalie, Dignat-George, Françoise, Rioux-Leclercq, Nathalie, Oudard, Stephane, Négrier, Sylvie, Ferrero, Jean-Marc, Chamorey, Emmanuel, Blot-Chabaud, Marcel, Pagès, Gilles
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2018
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928901/
https://ncbi.nlm.nih.gov/pubmed/29721091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.23002
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items